Taking the No. 5 spot is MasterCard (MA)
MasterCard services and supports credit, debit and other related payments to financial institutions. This company is surprassing many simply because of the worldwide trend which ultimately leads up to card usage, cash and checks through the company. MasterCard shares have returned an astounding average of 30% a year for the past five years. This year, the company has a cool 60% gain. According to Standard & Poor’s, MasterCard may see a new high of $400; that was the price target issued by them. Projecting a 25% increase in the company’s revenue this year alone, and 13% this coming year. MasterCard is curretnly at the top of all payment processors and are looking to remain on top.

At the No. 4 spot, we have Biogen Idec (BIIB)
Biogen Idec is a biotechnology company whose main concern is developing drugs for neurological disorders and other medical conditions. The main thing this biotech company focuses on is intreatments for autoimmune disorders. You may be wondering where did this company come from and how come they are soaring above many other biotech companies…well, according to money.msn, the recent approval of a new five-year European marketing plan for multiple sclerosis drug Tysabri and positive findings from a study of Avonex, another multiple sclerosis drug, have attracted investors. From what I can see, this company has a vast network of strong investors who are backing up this company 100%. As of today, there are several products already in/entering Phase III clinical trials. According to Standard & Poor’s, they expect Biogen Idec to have a revenue growth of 3.5% this coming year. This year, there was a 6% increase in revenue growth; with a total gain of 64%.

Next up, at the No. 3 spot we have Intuitive Surgical (ISRG)
Intuitive Surgical focuses on producing and selling a device known as the da Vinci Surgical System, which is a robot-assisted surgical device that allows surgeons to perform complex procedures; those include open-heart surgery with incisons as small as 1- to 2-centimeters. According to Standard & Poor’s, they see an increase of $14 per-share earnings in 2012, up from this year’s $11.90. Intuitive Surgical has topped this year with a 68% gain.

To no suprise, at our No. 2 spot is El Paso (EP)
El Paso is a huge company whose main goals focus in gas transportation and storage. In October, El Paso was acquired by Kinder Morgan (KMI) for a whopping $38 billion. What do you have when you combine El Paso with Kinder Morgan’s pipeline operations? The nation’s largest midstream energy transporation company. It gets even better, at this given point in time, demand for natrual gas is at an all-time high and continues to grow. El Paso ended the year with a 83% gain.

At our No. 1 spot is Cabot Oil & Gas (COG)
Cabot Oil & Gas is known for their vast network of exploring and producing natural gas, as well as a little bit of oil. The company is currently expanding and venturing onto new endeavors. Cabot Oil & Gas currently has an open project with Marcellus Shale, operating in northern Appalachia, which is producing natural gas. There are also mass operations in the Rockies and the Gulf Coast. As of today, this company is one of the earliest and biggest players in the oil industry. Cabot Oil & Gas is projected to grow to $2.95 per share in the year of 2012, up from $2.74 per share this year. Cabot Oil & Gas ends 2011 with a total gain of 90%.